Navigation Links
Study Data Show INTUNIV™ (guanfacine) Extended Release Tablets Co-administered With Stimulants Provided ADHD Symptom Improvement in Children and Adolescents
Date:5/21/2010

tudy, no unique adverse events were observed with INTUNIV given with stimulant compared with those reported with either treatment alone.  The most commonly reported treatment emergent adverse events (TEAEs) among patients treated with INTUNIV and a stimulant (greater than or equal to 5 percent) were headache, somnolence, upper respiratory tract infection, fatigue, insomnia, upper abdominal pain, dizziness, decreased appetite, cough, irritability, and nausea.  The most commonly reported TEAEs among patients in the placebo/stimulant group were headache, upper respiratory tract infection, and irritability.  The majority of TEAEs were mild to moderate in severity.   The rate of discontinuation due to TEAEs was 2.7 percent in the INTUNIV AM/stimulant group, 3.9 percent in the INTUNIV PM/stimulant group, and 0.7 percent in the placebo/stimulant group.  There were three serious adverse events reported among study participants (including one report of syncope) and all were considered unrelated to study drug.  No deaths occurred during the study.

"Shire is committed to ADHD and continues to develop a range of ADHD treatments for health care providers and patients," said Michael Yasick, Senior Vice President of Shire's ADHD Business Unit.  "We are pleased with the results of this trial and are currently working with the FDA to secure an indication for use of INTUNIV with stimulants in the treatment of ADHD."  

This study was supported by funding from Shire Development Inc.  Dr Timothy Wilens was a speaker and received grant support from and is a consultant for Shire.  

*Suboptimal response was defined as treatment with a stable dose of stimulant for at least four weeks with improvement, yet persistence of mild to moderate ADHD symptoms (defined as an ADHD-RS-IV total score of at least 24 an
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amsterdam Molecular Therapeutics Reports Promising Data From Cholesterol Lowering Gene Therapy Study
2. New Prime Therapeutics Study Finds Antiviral Medications Were Not Hoarded During H1N1 Flu Season
3. New Study Shows ENJUVIA® Significantly Reduced Sleep Time Awakenings Caused by Hot Flashes in Postmenopausal Women
4. ThromboGenics and BioInvent to Receive EUR10 Million Milestone as Partner Roche Begins New Clinical Study with TB-403
5. Whistleblower Lawyers Comment on New England Journal of Medicine Study
6. Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations
7. QRxPharma Successfully Completes Comparative Phase 1 Proof-of-Concept Study for MoxDuo(R) CR Tablet Formulation
8. QRxPharma Releases Additional Pivotal Phase 3 Combination Rule Study Data for MoxDuo(R)IR in Patients with Post-Surgical Pain
9. Spiral Enteroscopy is Three Times Faster than Double-Balloon Enteroscopy in Diagnosing the Small Intestine, New Study Finds
10. SARcode Corporation Announces Phase 2 Study Results of SAR 1118 Topical Ophthalmic Solution for the Treatment of Dry Eye
11. BetterInvesting Magazine Releases Julys Stock to Study and Undervalued Stock Choices for Investors Informational and Educational Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... April 20, 2015   Gateway Rehab ... Training Institute today expanded its Naloxone: Increasing Access, ... A $50,000 grant from the Staunton Farm ... possible.  The yearlong research project, ... and their family members upon completion of treatment ...
(Date:4/20/2015)... Pharmaceutical Research and Manufacturers of America,s (PhRMA) member companies ... research and development (R&D) of new innovative treatments and ... R&D spending – both public and private – in ... R&D numbers, the result of a recent survey of ... PhRMA 2015 Biopharmaceutical Research Industry Profile ...
(Date:4/20/2015)... STAMFORD, Conn. , April 20, 2015 /PRNewswire/ ... announced that Alan Butcher has joined ... & Business Development. Alan will have responsibility for ... commercial, near-commercial, and development-stage products that would benefit ... bringing aboard a proven leader," said Purdue President ...
Breaking Medicine Technology:Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 2Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 3PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 2PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 3Purdue Pharma Names J. Alan Butcher Senior Vice President of Licensing & Business Development 2
... RUTHERFORD, N.J., Nov. 1, 2011 Cambrex Corporation (NYSE: ... financial results will be released on Thursday, November 3, ... Company will host a conference call to discuss the ... CallWhen: , Friday, November 4, 2011 at 8:30 a.m. ...
... Fla., Nov. 1, 2011 When you are behind the ... move – looking at vehicles ahead and to the side, ... shifting your gaze inside and outside your vehicle in order ... or change a radio station. During darkness these ...
Cached Medicine Technology:Steering Drivers in the Right Direction, "Healthy Vision™ With Dr. Val Jones" Radio Show Offers Information, Advice About Driving in the Dark 2Steering Drivers in the Right Direction, "Healthy Vision™ With Dr. Val Jones" Radio Show Offers Information, Advice About Driving in the Dark 3
(Date:4/20/2015)... (PRWEB) April 20, 2015 Saint Joseph Regional ... 15 Top Health Systems by Truven Health Analytics, a leading ... quality of healthcare. SJRMC has been recognized by Truven Health ... the past four years. , According to Truven Health Analytics' ... Health Systems, in matchups with their peers, set the standard ...
(Date:4/20/2015)... A recent cross-sectional survey involving fibromyalgia patients ... 10 most beneficial therapies for fibromyalgia, no drugs were mentioned, ... only approved drugs were named. , “The biggest problem ... is only felt as long as the patient is taking ... “On the other hand, aerobic exercise and other non-drug approaches ...
(Date:4/20/2015)... 2015 Western Connecticut Health Network ... NEA-BC, FAAN who was named The Beatrice Hofstadter ... in September 2014, is transitioning from her current ... the development of Western Connecticut Health Network’s Nurse ... Donahue will be responsible for the identification and ...
(Date:4/20/2015)... 2015 Advance Home Care Supply ... that many customers would prefer not to share with others. ... a discreet delivery method allowing customers to order the products ... home without fear of a neighbor or passerby knowing what ... available now on all orders and no minimum order limit ...
(Date:4/20/2015)... Genuine fat loss results can seem virtually impossible ... the past. But what failed dieters and gym-goers don’t realize ... by adhering to five simple principles. , 1. Nutrition, No ... hours one spends working at the gym, a poor diet ... nutritional mean plan does not mean starvation, calorie counting or ...
Breaking Medicine News(10 mins):Health News:SJRMC Named a 15 Top Health System by Truven Health Analytics 2Health News:SJRMC Named a 15 Top Health System by Truven Health Analytics 3Health News:Medical Doctor in Huntsville Reveals That Aerobic Exercise Offers Best Results in Fibromyalgia Treatment 2Health News:Nursing Executive to Develop and Lead Nursing Leadership Program at Western Connecticut Health Network 2Health News:Advance Home Care Supply Proud to Offer Discreet Delivery For All Orders 2Health News:Advance Home Care Supply Proud to Offer Discreet Delivery For All Orders 3Health News:Guarantee Fat Loss Results With 5 Easy Tips 2Health News:Guarantee Fat Loss Results With 5 Easy Tips 3
... light to medium smokers, daily intake of non-steroidal anti-inflammatory drugs ... ,Norwegian scientists, who had conducted the studies, had said ... 65% less chance of having oral cancer than others, when ... suggested that NSAID might have anti carcinogenic effect on smokers ...
... improve the rate of recovery for the patients. Patients who had ... // having a favorable recovery than persons who have not been ... had the chance of 2.6 times more of a favorable recovery ... who had ischemic stroke to assess the usefulness of statins before ...
... a report prepared for the Health And Safety Executive, a ... of the employees,// researchers had found out that working in ... people work during nights, the levels of melatonin, or the ... with the new sleep routines. As a result, people do ...
... Technologies had developed a robotic dental drill that can make ... dental surgeon. The drill is all set to bring relief ... less painful than the common manual procedure. ,A dental ... and is generally imbedded in the gum through a long ...
... cancer is enhanced by eating processed meats, said the researchers ... Honolulu. ,Previous studies have tried to relate meat with ... have been proved to enhance carcinogenic growth in the pancreas. ... but the chemical agents that process the meat for long ...
... US department of Agriculture has recently unveiled a new guide to ... different needs. ,Based on the idea that same diet pattern ... on age, sex and the level of activity. The new plan ... gives you a diet chart once you feed in the required ...
Cached Medicine News:
... Right for the typical patient, right ... Medical ICDs, you have the ability to ... when you least expect themeven after implant. ... you need to be prepared in almost ...
... ID and Visitor Control System. A bar code-based ... compare and verify identity of those people authorized ... document interactions with all visitors and staff who ... child patient. It also helps to reduce the ...
... global companies a cost-effective and dependable ... initiatives. With die-cast metal construction, centralized ... options, and complex multi-language font support, ... Plus, the fully integrated RFID reader/encoder ...
... solid, tested XiIIIPlus platform, the R110Xifor ... of on-demand printing flexibility in tag ... such as XML for seamless integration ... inlay positioning, multiple power levels, statistics ...
Medicine Products: